Literature DB >> 22255547

Development of a wireless electromyographically controlled electrolarynx voice prosthesis.

James T Heaton1, Mark Robertson, Cliff Griffin.   

Abstract

The most common artificial voice source for post-laryngectomy speech rehabilitation is the handheld buzzer or electrolarynx (EL). EL speech is often described as mechanical-sounding (robotic), and typically lacks pitch variation, making it monotone and unnatural. Prior studies have shown improved perceptual ratings of speech naturalness when pitch variation is added to EL speech, and a proof-of-concept EL prosthesis has been developed to provide pitch variation and voice on/off control in relation to neck muscle electromyographic (EMG) signals. The goal of the present study was to design a new wireless version of the EMG-controlled EL (EMG-EL) that could provide a flexible mixture of manual (push button) and automatic (EMG-based) control options for voice onset/offset and pitch, and that could be manufactured at a reasonable cost for widespread patient use. This paper describes both technical and human factors considered while designing the new EMG-EL voice prosthesis.

Entities:  

Mesh:

Year:  2011        PMID: 22255547      PMCID: PMC8981260          DOI: 10.1109/IEMBS.2011.6091324

Source DB:  PubMed          Journal:  Annu Int Conf IEEE Eng Med Biol Soc        ISSN: 2375-7477


  10 in total

1.  Recurrent laryngeal nerve transposition in guinea pigs.

Authors:  J T Heaton; J B Kobler; E A Goldstein; T A McMahon; D T Barry; R E Hillman
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-10       Impact factor: 1.547

2.  Design and implementation of a hands-free electrolarynx device controlled by neck strap muscle electromyographic activity.

Authors:  Ehab A Goldstein; James T Heaton; James B Kobler; Garrett B Stanley; Robert E Hillman
Journal:  IEEE Trans Biomed Eng       Date:  2004-02       Impact factor: 4.538

3.  Surface electromyographic activity in total laryngectomy patients following laryngeal nerve transfer to neck strap muscles.

Authors:  James T Heaton; Ehab A Goldstein; James B Kobler; Steven M Zeitels; Gregory W Randolph; Michael J Walsh; John E Gooey; Robert E Hillman
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-09       Impact factor: 1.547

4.  Impact of aberrant acoustic properties on the perception of sound quality in electrolarynx speech.

Authors:  Geoffrey S Meltzner; Robert E Hillman
Journal:  J Speech Lang Hear Res       Date:  2005-08       Impact factor: 2.297

5.  Fundamental frequency variation with an electrolarynx improves speech understanding: a case study.

Authors:  Peter J Watson; Robert S Schlauch
Journal:  Am J Speech Lang Pathol       Date:  2008-12-23       Impact factor: 2.408

6.  The effect of fundamental frequency on the intelligibility of speech with flattened intonation contours.

Authors:  Peter J Watson; Robert S Schlauch
Journal:  Am J Speech Lang Pathol       Date:  2008-10-07       Impact factor: 2.408

7.  Development and perceptual evaluation of amplitude-based F0 control in electrolarynx speech.

Authors:  Yoko Saikachi; Kenneth N Stevens; Robert E Hillman
Journal:  J Speech Lang Hear Res       Date:  2009-06-29       Impact factor: 2.297

8.  Electromyographic control of a hands-free electrolarynx using neck strap muscles.

Authors:  Heather L Kubert; Cara E Stepp; Steven M Zeitels; John E Gooey; Michael J Walsh; S R Prakash; Robert E Hillman; James T Heaton
Journal:  J Commun Disord       Date:  2009-01-19       Impact factor: 2.288

9.  Training effects on speech production using a hands-free electromyographically controlled electrolarynx.

Authors:  Ehab A Goldstein; James T Heaton; Cara E Stepp; Robert E Hillman
Journal:  J Speech Lang Hear Res       Date:  2007-04       Impact factor: 2.297

10.  Neck and face surface electromyography for prosthetic voice control after total laryngectomy.

Authors:  Cara E Stepp; James T Heaton; Rebecca G Rolland; Robert E Hillman
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2009-03-16       Impact factor: 3.802

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.